oncoalert oncologist dr. matteo lambertini discusses the e2108 trial presented at #asco20
Published 4 years ago • 27 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
2:04
oncoalert oncologist dr. evandro de azambuja discusses the kaitlin trial presented at #asco20
-
2:58:58
the oncoalert colloquium day 3 breast cancer
-
2:58:57
the oncoalert colloquium day 3 breast cancer
-
2:19
dr. matteo lambertini at sabcs20 on fertility after breast cancer for oncoalert
-
3:21:26
the 2022 oncoalert colloquium day 1: breast cancer
-
3:22
evaluating tarlatamab in recurrent small cell lung cancer treatment
-
31:11
targeting tumor associated macrophages in ovarian cancer
-
32:15
estrogen receptor targeted pet/ct in invasive lobular breast cancer
-
7:06
clinical insights into breast cancer trials | matteo lambertini
-
2:07:58
multidisciplinary perspectives in breast cancer
-
2:20
oncoalert poster on attitudes of sbrt in oligometastatic breast cancer
-
2:20
the oncoalert ecancer weekly round up october 10-16, 2021
-
0:45
lung cancer, hematology/oncology clinic, baton rouge, la
-
13:15
spinal oncology (part 1 of 3)
-
2:20
the oncoalert ecancer weekly round up october 23, 2021
-
1:09
dr. rao on the soft trial in patients with premenopausal breast cancer
-
2:00
rna profiling of circulating tumor cells in myeloma patients
-
0:58
exploring biosimilars in the field of breast cancer
-
1:03
azd2014 for treating er metastatic breast cancer – mode of action and trial results
-
0:16
breast cancer: daina pack, md, talks breast cancer risk at anne arundel medical center (aamc)
-
5:17
dr alvaro alencar, md
-
0:54
oncotarget: atr inhibition reverses cancer cell resistance to temozolomide